NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market on Tuesday that revenues in the second quarter increased 1 percent year over year.

The company also said that its board has approved a $750 million share repurchase program on top of the $62 million that remains from its existing repurchase program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.